Polaris ADMET
Industry-contributed ADMET benchmarks on Polaris Hub (Novartis/AstraZeneca/Polaris SC curated endpoints).
Composite score: 88.4
Rubric (1–5 per criterion)
rigor
5/5
coverage
4/5
maintenance
5/5
adoption
3/5
quality
5/5
accessibility
4/5
industry_relevance
5/5
Metadata
Stages
Lead ID / ADMET
Modalities
small-molecule
Task types
regressionclassification
License
Polaris Community
First release
2023-10
Last updated
2025-04
Flags
none
Size & scope
- endpoints: 12
- molecules: 50000
Primary paper
Title
Polaris: method comparison in drug discovery
Authors
Wognum C, Noutahi E, Hsu J, et al.
Year
2024
DOI / arXiv
N/A — working paper
Citations
30
Links
- Official site: https://polarishub.io/benchmarks
- GitHub: https://github.com/polaris-hub/polaris
- Leaderboard: https://polarishub.io/benchmarks
Hosted by (initiatives)
Experts (primary authors / maintainers)
Groups (host labs / companies / consortia)
Related benchmarks
Notes (honest caveats)
Industry splits enforce blinded eval; highest industry relevance among ADMET benchmarks.